about
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a ...
Read More
11.42
0.24
(2.15%)
3.0M
XNAS Volume
XNAS 23 Jun, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Replimune Grp Inc is on 26 Jun 2026 for the purpose of Replimune Group Inc Annual Report for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Replimune Grp Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..